Reflections on the Potential and Risks of AI for Scientific Article Writing after the AI Endorsement by Some Scientific Publishers: Focusing on Scopus AI.

IF 1 4区 医学 Q4 NEUROSCIENCES
Jose De Leon, Santiago De Leon-Martinez, Antonio Artés-Rodríguez, Enrique Baca-García, Carlos De Las Cuevas
{"title":"Reflections on the Potential and Risks of AI for Scientific Article Writing after the AI Endorsement by Some Scientific Publishers: Focusing on Scopus AI.","authors":"Jose De Leon, Santiago De Leon-Martinez, Antonio Artés-Rodríguez, Enrique Baca-García, Carlos De Las Cuevas","doi":"10.62641/aep.v53i2.1849","DOIUrl":null,"url":null,"abstract":"<p><p>The introduction of ChatGPT3 in 2023 disrupted the field of artificial intelligence (AI). ChatGPT uses large language models (LLMs) but has no access to copyrighted material including scientific articles and books. This review is limited by the lack of access to: (1) prior peer-reviewed articles and (2) proprietary information owned by the companies. Despite these limitations, the article reviews the use of LLMs in the publishing of scientific articles. The first use was plagiarism software. The second use by the American Psychological Association and Elsevier helped their journal editors to screen articles before their review. These two publishers have in common a large number of copyrighted journals and textbooks but, more importantly, a database of article abstracts. Elsevier is the largest of the five large publishing houses and the only one with a database of article abstracts developed to compete with the bibliometric experts of the Web of Science. The third use and most relevant, Scopus AI, was announced on 16 January 2024, by Elsevier; a version of ChatGPT-3.5 was trained using Elsevier copyrighted material written since 2013. Elsevier's description suggests to the authors that Scopus AI can write review articles or the introductions of original research articles with no human intervention. The editors of non-Elsevier journals not willing to approve the use of Scopus AI for writing scientific articles have a problem on their hands; they will need to trust that the authors who have submitted articles have not lied and have not used Scopus AI at all.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"53 2","pages":"433-442"},"PeriodicalIF":1.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11898249/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Actas espanolas de psiquiatria","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62641/aep.v53i2.1849","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

The introduction of ChatGPT3 in 2023 disrupted the field of artificial intelligence (AI). ChatGPT uses large language models (LLMs) but has no access to copyrighted material including scientific articles and books. This review is limited by the lack of access to: (1) prior peer-reviewed articles and (2) proprietary information owned by the companies. Despite these limitations, the article reviews the use of LLMs in the publishing of scientific articles. The first use was plagiarism software. The second use by the American Psychological Association and Elsevier helped their journal editors to screen articles before their review. These two publishers have in common a large number of copyrighted journals and textbooks but, more importantly, a database of article abstracts. Elsevier is the largest of the five large publishing houses and the only one with a database of article abstracts developed to compete with the bibliometric experts of the Web of Science. The third use and most relevant, Scopus AI, was announced on 16 January 2024, by Elsevier; a version of ChatGPT-3.5 was trained using Elsevier copyrighted material written since 2013. Elsevier's description suggests to the authors that Scopus AI can write review articles or the introductions of original research articles with no human intervention. The editors of non-Elsevier journals not willing to approve the use of Scopus AI for writing scientific articles have a problem on their hands; they will need to trust that the authors who have submitted articles have not lied and have not used Scopus AI at all.

部分科学出版商认可AI后对AI在科技文章写作中的潜力和风险的思考:聚焦Scopus AI
2023年ChatGPT3的引入颠覆了人工智能(AI)领域。ChatGPT使用大型语言模型(llm),但无法访问包括科学文章和书籍在内的受版权保护的材料。由于无法获得:(1)先前的同行评议文章和(2)公司拥有的专有信息,本综述受到限制。尽管有这些限制,文章回顾了法学硕士在发表科学文章中的使用。第一个用途是抄袭软件。美国心理学会(American Psychological Association)和爱思唯尔(Elsevier)的第二个用途是帮助他们的期刊编辑在评审前筛选文章。这两家出版商共同拥有大量受版权保护的期刊和教科书,但更重要的是,他们拥有一个文章摘要数据库。爱思唯尔是五家大型出版社中最大的一家,也是唯一一家拥有文章摘要数据库的出版社,其开发目的是与科学网的文献计量专家竞争。2024年1月16日,爱思唯尔(Elsevier)宣布了第三种用途,也是最相关的Scopus AI;ChatGPT-3.5的一个版本是使用爱思唯尔自2013年以来编写的版权材料进行培训的。爱思唯尔的描述向作者暗示,Scopus AI可以在没有人为干预的情况下撰写评论文章或原创研究文章的介绍。非爱思唯尔期刊的编辑不愿意批准使用Scopus人工智能撰写科学文章,这是一个问题;他们需要相信提交文章的作者没有撒谎,也根本没有使用Scopus人工智能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Actas espanolas de psiquiatria
Actas espanolas de psiquiatria 医学-精神病学
CiteScore
1.70
自引率
6.70%
发文量
46
审稿时长
>12 weeks
期刊介绍: Actas Españolas de Psiquiatría publicará de manera preferente trabajos relacionados con investigación clínica en el área de la Psiquiatría, la Psicología Clínica y la Salud Mental.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信